Rainbow Children's Medicare Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Rainbow Children's Medicare Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: For every ₹100 of sales, ₹1 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹3 from others' credit three years earlier. Less money tied up than 86% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹154Over the last 3 years, every ₹100 of reported profit came with ₹154 of operating cash.
Higher than 71% of Healthcare companies in India.
Self-Funding Ratio
1.6×Over the last 3 years its own operating cash covered its investment spending (capex) 1.6 times.
Higher than 61% of Healthcare companies in India.
Cash Locked Ratio
₹1For every ₹100 of sales, ₹1 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹3 from others' credit three years earlier.
Less money tied up than 86% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹13Sales grew 45% in 3 years; of every extra ₹100 of sales, ₹13 became extra profit.
Lower than 62% of Healthcare companies in India.
Asset Productivity Ratio
+45% / +57%In 3 years sales changed by +45% while total assets changed by +57%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
16.4×Debt due within a year is covered 16.4 times by its yearly operating cash.
Higher than 80% of Healthcare companies in India.
Cash Cushion Ratio
−3%Debt, after subtracting cash, equals 3% of its market value (net debt).
Lower than 58% of Healthcare companies in India.
Tangible Assets Ratio
93%Of every ₹100 the company owns, ₹93 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 64% of Healthcare companies in India.
Tangible Net Worth Ratio
88%Of every ₹100 of net worth, ₹88 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 63% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Rainbow Children's Medicare Limited owes ₹0.40 for every ₹1 it owns. Net profit rose 14% in the year to Mar 2026, and grew 10% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
41.6Investors pay ₹41.6 for every ₹1 of Rainbow Children's Medicare Limited's yearly profit, higher than 58% of Healthcare companies in India.
P/B ratio
7.20The share price is 7.20 times Rainbow Children's Medicare Limited's book value per share, higher than 74% of Healthcare companies in India.
Market cap
₹11,866 CrThe total market value of all of Rainbow Children's Medicare Limited's shares at today's price (share price × number of shares), larger than 66% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹1,648 CrWhat Rainbow Children's Medicare Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹162.45Net worth divided by the number of shares. The share price of ₹1,170 is 7.2 times this, which is the P/B above.
Return on equity (ROE)
17.3%Rainbow Children's Medicare Limited earned 17.3% on its shareholders' money over the last year, higher than 70% of Healthcare companies in India.
Owes vs Owns
0.40×Rainbow Children's Medicare Limited owes ₹0.40 for every ₹1 it owns (low), higher than 60% of Healthcare companies in India.
Dividend yield
0.28%Rainbow Children's Medicare Limited pays 0.28% of its share price as dividends a year, lower than 60% of dividend-paying Healthcare companies in India.
Revenue growth
+12%Revenue rose 12% in the year to Mar 2026, and grew 13% a year on average over 3 years.
Profit growth
+14%Net profit rose 14% in the year to Mar 2026, and grew 10% a year on average over 3 years.
Profit margin
16.6%Rainbow Children's Medicare Limited keeps ₹17 of every ₹100 of revenue as net profit.
Cash quality
1.5×Cash from Rainbow Children's Medicare Limited's business was 1.5× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
5.1×Rainbow Children's Medicare Limited's operating profit covered its interest costs 5.1 times in the year to Mar 2026.
Cash vs debt
Net debtRainbow Children's Medicare Limited had ₹404 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Rainbow Children's Medicare Limited's P/E ratio?
Investors pay ₹41.6 for every ₹1 of Rainbow Children's Medicare Limited's yearly profit, higher than 58% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Rainbow Children's Medicare Limited: ₹11,866 Cr ÷ ₹1,648 Cr (31 Mar 2026) = 7.2.
What is Rainbow Children's Medicare Limited's return on equity?
Rainbow Children's Medicare Limited earned 17.3% on its shareholders' money over the last year, higher than 70% of Healthcare companies in India.
How much does Rainbow Children's Medicare Limited owe compared with what it owns?
Rainbow Children's Medicare Limited owes ₹0.40 for every ₹1 it owns (low), higher than 60% of Healthcare companies in India.
Does Rainbow Children's Medicare Limited pay a dividend?
Yes. Rainbow Children's Medicare Limited pays 0.28% of its share price as dividends a year, lower than 60% of dividend-paying Healthcare companies in India.
Is Rainbow Children's Medicare Limited's revenue growing?
Revenue rose 12% in the year to Mar 2026, and grew 13% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.